Goblet cell carcinoid (GCC) tumours of the appendix represent a unique and diagnostically challenging subset of neoplasms that manifest with dual characteristics of both neuroendocrine and ...
Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced the first patient has been randomized in the pivotal Phase 3 CAREFNDR trial, a multicenter, randomized, double-blind, placebo-controlled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback